LUP.SG

Luye Pharma Group Ltd
StuttgartEUREQUITY DELAYED
Last price
0.19
▼ 0.01 (2.50%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
0.20
Prev close
0.20
Day high
0.20
Day low
0.20
Volume
0
Market cap
—
P/E (TTM)
—
52W range
0.10 – 0.37

Day trading desk

Current session · delayed
Gap from prior close
-0.50%
Prior close 0.20
VWAP
—
—
Relative volume
—
—
Session range
3.59%
0.19 – 0.20
Position in range
0%
Near session low
ATR (14D)
0.01
5.60% of price
Prior day high
0.20
PDH
Prior day low
0.20
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Shares traded

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-4.41% -6.4%
1M
-3.47% -5.0%
3M
-6.25% -9.7%
6M
-34.56% -49.6%
YTD
-29.35% -43.4%
1Y
-47.58% -63.4%
3Y
-51.49% -133.5%
5Y
-50.51% —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on LUP.SG open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—

Valuation & profitability ratios

Account required
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 2 quarters
Blank means not reported, not zero
Line item20252024202320222021YoY
Total revenue $6.31B$6.06B$6.14B$5.98B— +4.1%
Operating revenue $6.31B$6.06B$6.14B$5.98B— +4.1%
Cost of revenue $2.15B$2.02B$1.94B$1.84B— +6.4%
Gross profit $4.16B$4.04B$4.20B$4.14B— +2.9%
Research & development $413.92M$498.59M$586.16M$857.34M— -17.0%
Selling, general & admin $2.51B$2.40B$2.70B$2.40B— +4.5%
Total operating expense $2.91B$2.75B$3.18B$3.19B— +5.6%
Operating income $1.26B$1.29B$1.03B$953.88M— -2.7%
Net interest income -$590.49M-$477.35M-$558.32M-$383.08M— -23.7%
Pre-tax income $944.64M$839.22M$700.10M$669.76M— +12.6%
Tax provision $238.98M$194.21M$161.02M$86.47M— +23.1%
Net income $618.75M$471.89M$532.61M$604.81M— +31.1%
Net income to common $618.75M$471.89M$532.61M$604.81M— +31.1%
Basic EPS 0.160.130.140.17— +26.6%
Diluted EPS 0.13—0.140.17-0.04 —
EBIT $1.63B$1.40B$1.38B$1.14B— +16.4%
EBITDA $2.47B$2.19B$2.08B$1.81B— +12.7%
Basic shares 3.90B3.76B3.73B3.48B— +3.6%
Diluted shares 6.02B3.76B3.73B3.48B— +60.0%

Options analytics

Account required
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Analyst targets & ownership

Account required
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
0.20
-2.16% from price
SMA 20
0.20
-0.13% from price
SMA 50
0.21
-5.90% from price
SMA 100
0.21
-7.58% from price
SMA 200
0.25
-21.77% from price
EMA 12
0.20
-1.65% from price
EMA 26
0.20
-2.46% from price
EMA 50
0.21
-4.98% from price
RSI (14)
46.8
Neutral
MACD (12,26,9)
-0.00
Hist 0.00
ATR (14)
0.01
5.60% of price
Realised vol 30D
61.2%
Annualised
Bollinger upper
0.21
20, 2σ
Bollinger lower
0.18
20, 2σ
50 / 200 cross
Death
0.21 vs 0.25
Trend bias
Below 200
-21.77%

Options chain

Account required
Expiry
Spot 0.19
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.04
Less volatile than market
Correlation to SPY
0.00
Largely independent
Realised vol 30D
61.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-72.2%
Peak to trough
Max drawdown 5Y
-78.9%
Peak to trough
ATR 14
0.01
5.60% of price
Beta (reported)
—
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.